Steven Deitcher

Steven Deitcher

Company: Radimmune

Job title: President, Chief Executive Officer & Board Member


A Novel Approach to Targeting Radiopharmaceuticals 4:00 pm

• Discuss the rationale behind Radimmune’s selection of cancer targets • Discuss the merits of targeting extracellular accumulations of normally intracellular moietiesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.